Beckley Waves operates as a venture studio focused on building the infrastructure for responsible access to psychedelic medicines and therapies. The company supports emerging leaders and enterprises within the psychedelic sector. Its mission is to facilitate the safe, legal, and scalable deployment of psychedelic-assisted treatments.
Funding
$7.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The emerging field of psychedelic-assisted therapy faces challenges in establishing a robust and scalable operational infrastructure. Early-stage providers and platforms often lack the necessary resources and support to navigate complex regulatory landscapes and deliver treatments safely and effectively. This limits access to potentially beneficial therapies for individuals seeking alternative mental health solutions.
Solution
Beckley Waves is a venture studio that incubates and invests in companies building the operational infrastructure required for the legal and responsible delivery of psychedelic-assisted treatments. The studio provides funding, mentorship, and resources to early-stage ventures focused on enhancing access to safe psychedelic therapies. Beckley Waves supports companies developing innovative solutions across the psychedelic ecosystem, with a focus on safety, access, and responsible practices. The goal is to build and strengthen the foundational infrastructure that will support the responsible and lawful use of psychedelics to advance human wellbeing and consciousness.
Target Audience
The target audience includes early-stage companies and entrepreneurs in the psychedelic-assisted therapy space, as well as investors interested in supporting the development of this emerging field.
Features
- Venture studio model providing incubation and investment to early-stage psychedelic companies.
- Focus on companies building operational infrastructure for legal and responsible psychedelic-assisted treatments.
- Mentorship and resources to navigate regulatory landscapes and ensure safe treatment delivery.
- Emphasis on equitable access to psychedelic therapies.
- Support for companies developing innovative solutions across the psychedelic ecosystem.